U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240454) titled 'Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma' on Nov. 16.
Brief Summary: This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration. By participating in this study, participants can receive additional scientific guidance on aspirin medication management beyond routine conservative treatment, thereby optimi...